{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:42:38Z","timestamp":1790304158088,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00105-018-4318-z","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T06:15:47Z","timestamp":1543558547000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Klassifikation und Pathophysiologie von Angio\u00f6demen","Classification and pathophysiology of angioedema"],"prefix":"10.1007","volume":"70","author":[{"given":"T.","family":"Buttgereit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"4318_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40413-017-0180-1","author":"M Maurer","year":"2018","unstructured":"Maurer M, Magerl M, Ansotegui I, Aygoren-Pursun E, Betschel S, Bork K et al (2018) The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2017 revision and update. Allergy. \n                    https:\/\/doi.org\/10.1186\/s40413-017-0180-1","journal-title":"Allergy"},{"issue":"5","key":"4318_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1398-9995.2012.02795.x","volume":"67","author":"M Worm","year":"2012","unstructured":"Worm M, Edenharter G, Rueff F, Scherer K, Pfohler C, Mahler V et\u00a0al (2012) Symptom profile and risk factors of anaphylaxis in central Europe. Allergy 67(5):691\u2013698","journal-title":"Allergy"},{"issue":"7","key":"4318_CR3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","volume":"73","author":"T Zuberbier","year":"2018","unstructured":"Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B et al (2018) The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 73(7):1393\u20131414","journal-title":"Allergy"},{"issue":"6","key":"4318_CR4","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.jaci.2016.08.050","volume":"139","author":"P Kolkhir","year":"2017","unstructured":"Kolkhir P, Church MK, Weller K, Metz M, Schmetzer O, Maurer M (2017) Autoimmune chronic spontaneous urticaria: what we know and what we do not know. J\u00a0Allergy Clin Immunol 139(6):1772\u20131781.e1","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"4318_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejim.2013.11.003","volume":"25","author":"L Losappio","year":"2014","unstructured":"Losappio L, Heffler E, Bussolino C, Cannito CD, Carpentiere R, Raie A et\u00a0al (2014) Acute urticaria presenting in the emergency room of a\u00a0general hospital. Eur J Intern Med 25(2):147\u2013150","journal-title":"Eur J Intern Med"},{"issue":"3","key":"4318_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","volume":"66","author":"M Maurer","year":"2011","unstructured":"Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J et al (2011) Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 66(3):317\u2013330","journal-title":"Allergy"},{"issue":"8","key":"4318_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/all.12870","volume":"71","author":"P Staubach","year":"2016","unstructured":"Staubach P, Metz M, Chapman-Rothe N, Sieder C, Brautigam M, Canvin J et al (2016) Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X\u2011ACT, a\u00a0randomized controlled trial. Allergy 71(8):1135\u20131144","journal-title":"Allergy"},{"issue":"4","key":"4318_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/jdv.12661","volume":"29","author":"N Schoepke","year":"2015","unstructured":"Schoepke N, Mlynek A, Weller K, Church MK, Maurer M (2015) Symptomatic dermographism: an inadequately described disease. J\u00a0Eur Acad Dermatol Venereol 29(4):708\u2013712","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"4318_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaip.2016.09.029","volume":"5","author":"J Sanchez","year":"2017","unstructured":"Sanchez J, Amaya E, Acevedo A, Celis A, Caraballo D, Cardona R (2017) Prevalence of inducible urticaria in patients with chronic spontaneous urticaria: associated risk factors. J\u00a0Allergy Clin Immunol Pract 5(2):464\u2013470","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"4318_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/archderm.134.1.106","volume":"134","author":"P Mathelier-Fusade","year":"1998","unstructured":"Mathelier-Fusade P, Aissaoui M, Bakhos D, Chabane MH, Leynadier F (1998) Clinical predictive factors of severity in cold urticaria. Arch Dermatol 134(1):106\u2013107","journal-title":"Arch Dermatol"},{"issue":"12","key":"4318_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/j.1398-9995.2009.02177.x","volume":"64","author":"M Magerl","year":"2009","unstructured":"Magerl M, Borzova E, Gimenez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P et al (2009) The definition and diagnostic testing of physical and cholinergic urticarias\u2014EAACI\/GA2LEN\/EDF\/UNEV consensus panel recommendations. Allergy 64(12):1715\u20131721","journal-title":"Allergy"},{"issue":"4","key":"4318_CR12","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","volume":"343","author":"G Dewald","year":"2006","unstructured":"Dewald G, Bork K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343(4):1286\u20131289","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4318_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","volume":"141","author":"V Bafunno","year":"2018","unstructured":"Bafunno V, Firinu D, D\u2019Apolito M, Cordisco G, Loffredo S, Leccese A et al (2018) Mutation of the angiopoietin-1 gene (ANGPT1) associates with a\u00a0new type of hereditary angioedema. J\u00a0Allergy Clin Immunol 141(3):1009\u20131017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"4318_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/all.13270","volume":"73","author":"K Bork","year":"2018","unstructured":"Bork K, Wulff K, Steinmuller-Magin L, Braenne I, Staubach-Renz P, Witzke G et al (2018) Hereditary angioedema with a\u00a0mutation in the plasminogen gene. Allergy 73(2):442\u2013450","journal-title":"Allergy"},{"issue":"6","key":"4318_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjh.13908","volume":"172","author":"R Castelli","year":"2016","unstructured":"Castelli R, Wu MA, Arquati M, Zanichelli A, Suffritti C, Rossi D et\u00a0al (2016) High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. Br J Haematol 172(6):902\u2013908","journal-title":"Br J Haematol"},{"issue":"3","key":"4318_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.critrevonc.2013.02.004","volume":"87","author":"R Castelli","year":"2013","unstructured":"Castelli R, Zanichelli A, Cicardi M, Cugno M (2013) Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a\u00a0tight relationship. Crit Rev Oncol Hematol 87(3):323\u2013332","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"4318_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jaip.2016.12.032","volume":"5","author":"A Zanichelli","year":"2017","unstructured":"Zanichelli A, Azin GM, Wu MA, Suffritti C, Maggioni L, Caccia S et al (2017) Diagnosis, course, and management of angioedema in patients with acquired C1-inhibitor deficiency. J\u00a0Allergy Clin Immunol Pract 5(5):1307\u20131313","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"4318_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1056\/NEJMoa1312524","volume":"372","author":"M Bas","year":"2015","unstructured":"Bas M, Greve J, Stelter K, Havel M, Strassen U, Rotter N et al (2015) A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N\u00a0Engl J Med 372(5):418\u2013425","journal-title":"N Engl J Med"},{"issue":"10","key":"4318_CR19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/all.12680","volume":"70","author":"M Bas","year":"2015","unstructured":"Bas M, Greve J, Strassen U, Khosravani F, Hoffmann TK, Kojda G (2015) Angioedema induced by cardiovascular drugs: new players join old friends. Allergy 70(10):1196\u20131200","journal-title":"Allergy"},{"issue":"20","key":"4318_CR20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"S Toh","year":"2012","unstructured":"Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF et al (2012) Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med 172(20):1582\u20131589","journal-title":"Arch Intern Med"},{"issue":"3","key":"4318_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jaip.2017.02.018","volume":"5","author":"A Banerji","year":"2017","unstructured":"Banerji A, Blumenthal KG, Lai KH, Zhou L (2017) Epidemiology of ACE inhibitor angioedema utilizing a\u00a0large electronic health record. J\u00a0Allergy Clin Immunol Pract 5(3):744\u2013749","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"4318_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2340\/00015555-2233","volume":"96","author":"ER Rasmussen","year":"2016","unstructured":"Rasmussen ER, de Freitas PV, Bygum A (2016) Urticaria and prodromal symptoms including erythema marginatum in Danish patients with hereditary angioedema. Acta Derm Venereol 96(3):373\u2013376","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"4318_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1067\/mjd.2001.116217","volume":"45","author":"MM Kozel","year":"2001","unstructured":"Kozel MM, Mekkes JR, Bossuyt PM, Bos JD (2001) Natural course of physical and chronic urticaria and angioedema in 220 patients. J\u00a0Am Acad Dermatol 45(3):387\u2013391","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"4318_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1398-9995.2004.00473.x","volume":"59","author":"E Toubi","year":"2004","unstructured":"Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D et\u00a0al (2004) Clinical and laboratory parameters in predicting chronic urticaria duration: a\u00a0prospective study of 139 patients. Allergy 59(8):869\u2013873","journal-title":"Allergy"},{"issue":"5","key":"4318_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","volume":"34","author":"K Kulthanan","year":"2007","unstructured":"Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S (2007) Chronic idiopathic urticaria: prevalence and clinical course. J\u00a0Dermatol 34(5):294\u2013301","journal-title":"J Dermatol"},{"issue":"8","key":"4318_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2230.2010.03840.x","volume":"35","author":"T Zuberbier","year":"2010","unstructured":"Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M (2010) Epidemiology of urticaria: a\u00a0representative cross-sectional population survey. Clin Exp Dermatol 35(8):869\u2013873","journal-title":"Clin Exp Dermatol"},{"key":"4318_CR27","unstructured":"Urtikaria-Galerie: \n                    http:\/\/www.urtikaria.net\/de\/fuer-betroffene\/galerie\/album-urtikaria.html\n                    \n                  . letzter Zugriff: 25. Okt. 2018"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4318-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T19:16:00Z","timestamp":1575054960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4318-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4318"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4318-z","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"30 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Buttgereit gibt an, dass kein Interessenkonflikt besteht. M.\u00a0Maurer: Referent\/Berater und\/oder Empf\u00e4nger von Forschungsf\u00f6rderung Allakos, Almirall, AstraZeneca, Aralez, Bayer, BioCryst, FAES, Genentech, GSK, KalVista, Leo, Menarini, Merckle Recordati, Moxie, MSD, Novartis, Pharming, Riemser, Sanofi, Shire, Leo Pharma, Takeda, UCB und Uriach.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Falle von nicht m\u00fcndigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}